Middle East and Africa Respiratory Inhalers Market Report and Forecast 2025-2034

Middle East and Africa Respiratory Inhalers Market Size

The global respiratory inhalers market was valued at USD 33.5 billion in 2024, with the Middle East and Africa holding a significant market share. The market is driven by the rising burden of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is expected to grow at a CAGR of 5.4% during the forecast period of 2025-2034, with the values likely to attain USD 53.9 billion by 2034.

Middle East and Africa Respiratory Inhalers Market Outlook

• Recent data reveals that the prevalence of asthma is relatively high in the United Arab Emirates, affecting 10-15% of the adult population along with 20-25%  of school-aged children. Similarly, in South Africa, it causes substantial loss of life.

• One of the major Middle East and Africa respiratory inhalers market trends is the rising investments in the development of eco-friendly inhaler technology. In April 2024 , Mundipharma, in collaboration with Vectura announced plans to reformulate an established flutiform® pressurized metered-dose inhaler (pMDI), aiming to reduce the product’s carbon footprint by incorporating an environmentally friendly propellant.

• The market share is influenced by the growing preference for combination inhaler therapies which consist of multiple medications in a single inhaler device, thereby driving the demand for combination inhalers.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Middle East and Africa Respiratory Inhalers Market Analysis

Respiratory inhalers are used to administer medication directly into the lungs to treat respiratory conditions. These devices contain different types of medications such as bronchodilators (to relax the muscles in the airways), corticosteroids (to reduce inflammation), and combination therapies (containing both bronchodilators and corticosteroids). There is a growing shift towards the development of combination inhaler therapies which consists of multiple medications in a single inhaler device, driving the demand for combination inhalers (aerosol or dry powder inhalers). Further, the rising advancements in digital inhaler technologies such as smart inhalers are expected to significantly contribute to the Middle East and Africa respiratory inhalers market growth.

The market is influenced by rising burden of respiratory conditions that directly impact the demand for effective respiratory inhalers. Recent data reveals that the prevalence of asthma is relatively high in the United Arab Emirates, accounting for 10-15% of the adult population and 20-25%  of school-aged children. Similarly, it is estimated that over 10-15% of adults and 20% of children in South Africa  are affected by asthma along with a high number of deaths caused by the condition. This increasing prevalence of respiratory diseases, attributed to factors such as smoking, air pollution, and changing lifestyle patterns, is anticipated to fuel the Middle East and Africa respiratory inhalers market demand in the coming years.

One of the major market trends include an increasing focus on the development of eco-friendly inhaler technologies in the region. For instance, in April 2024 , Mundipharma (a global healthcare company with a strong presence in the Middle East and Africa) in collaboration with contract development and manufacturing organization (CDMO) Vectura announced plans to reformulate an established flutiform® pressurized metered-dose inhaler (pMDI) for asthma treatment. The remodelling aims at reducing the product’s carbon footprint by incorporating an environment friendly propellant. The growing efforts toward the advancement of respiratory inhaler technology with a lower environmental impact is projected to elevate the market value.

Middle East and Africa Respiratory Inhalers Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Leading Players in the Middle East and Africa Respiratory Inhalers Market

The key features of the market report include funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• AstraZeneca Plc
• Beximco Pharmaceuticals Ltd.
• Boehringer Ingelheim International GmbH
• Cipla Ltd
• GSK Plc
• Koninklijke Philips NV
• OMRON Corp
• Pari Respiratory Equipment, Inc.
• Teva Pharmaceutical Industries Ltd
• OPKO Health, Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

Our Top Selling Reports

Ataxia Market

Trocar Market

Stents Market

C-arms Market

CBD Oil Market

Biochip Market

Femtech Market

mHealth Market

Vaccine Market

Albumin Market

Middle East and Africa Respiratory Inhalers Market Report Snapshots

Middle East and Africa Respiratory Inhalers Market Size

Middle East and Africa Respiratory Inhalers Market Analysis

Middle East and Africa Respiratory Inhalers Companies